Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-026891

EVP and COO sold 330 shares at $11.75 ($3,878)

  • EVP and COO acquired 962 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wolff Stefani EVP and COO 2022-04-30 Option exercise +962 962 D: show line 1 in the form
Wolff Stefani EVP and COO 2022-05-02 Sale −330 $11.75 $3,878 632 D: show line 2 in the form
Open-market sales · 330 sh · avg $11.75 · $3,878

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Wolff Stefani EVP and COO 2022-04-30 Option exercise · Restricted Stock Units −962 14,430 D: show line 3 in the form
Loading xslF345X03/doc4.xml…